Anavex Life Sciences (AVXL) Selling, General & Administrative (2016 - 2026)
Anavex Life Sciences' Selling, General & Administrative was $2.29 million in fiscal Q2 2026 (quarter ended Mar 31, 2026), down 12.6% from $2.62 million a year earlier but up 7.8% from the prior quarter.
Anavex Life Sciences (AVXL) Selling, General & Administrative (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Anavex Life Sciences' Selling, General & Administrative was $12.47 million through Mar 31, 2026, up 11.2% year-over-year; for FY2025 (ended Sep 30, 2025), it was $13.82 million, up 25.2% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of 18.7% (FY2020 to FY2025).
- In earlier fiscal years, Selling, General & Administrative was $11.04 million in FY2024 (-8.4%), $12.05 million in FY2023 (-7.8%), $13.07 million in FY2022 (+44.9%) and $9.02 million in FY2021 (+54.0%).
- Quarterly Selling, General & Administrative has moved between $2.13 million (fiscal Q1 2026) and $4.5 million (fiscal Q3 2025) over five years.
- Compared with a year earlier, Selling, General & Administrative was higher in four of the last eight quarters, with growth averaging 5.7%.
- The best year-over-year quarter for Selling, General & Administrative over five years was fiscal Q1 2022 (growth of 108.5%); the worst was fiscal Q4 2023 (a decline of 33.4%).
- Per Business Quant data, AVXL's Selling, General & Administrative in the three fiscal quarters before Q2 2026 was $2.13 million (Q1 2026), $3.55 million (Q4 2025) and $4.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Anavex Life Sciences | 168.71 Mn | -311.37 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.29 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Sep 30, 2025 | 3.55 Mn |
| Jun 30, 2025 | 4.50 Mn |
| Mar 31, 2025 | 2.62 Mn |
| Dec 31, 2024 | 3.15 Mn |
| Sep 30, 2024 | 2.66 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Sep 30, 2023 | 2.60 Mn |
| Jun 30, 2023 | 3.25 Mn |
| Mar 31, 2023 | 2.88 Mn |
| Dec 31, 2022 | 3.32 Mn |
| Sep 30, 2022 | 3.90 Mn |
| Jun 30, 2022 | 3.19 Mn |
| Mar 31, 2022 | 2.92 Mn |
| Dec 31, 2021 | 3.07 Mn |
| Sep 30, 2021 | 2.88 Mn |
| Jun 30, 2021 | 2.43 Mn |
Anavex Life Sciences Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();